Connor, Clark & Lunn Investment Management Ltd. Ovid Therapeutics Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$22 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$2.72 - $4.04 $8,317 - $12,354	3,058 Added 3.77%	84,233 $256,000
Q4 2023 Feb 09, 2024	BUY	$2.98 - $3.78 $5 - $7	2 Added 0.0%	81,175 $261,000
Q3 2023 Nov 13, 2023	BUY	$3.23 - $3.97 $38,520 - $47,346	11,926 Added 17.22%	81,173 $311,000
Q2 2023 Aug 10, 2023	BUY	$2.53 - $3.89 $97,124 - $149,333	38,389 Added 124.41%	69,247 $227,000
Q1 2023 May 09, 2023	SELL	$1.88 - $2.85 $17,036 - $25,826	-9,062 Reduced 22.7%	30,858 $79,000
Q4 2022 Feb 10, 2023	SELL	$1.43 - $1.89 $3,810 - $5,036	-2,665 Reduced 6.26%	39,920 $74,000
Q3 2022 Nov 10, 2022	BUY	$1.84 - $2.26 $10,740 - $13,191	5,837 Added 15.88%	42,585 $78,000
Q2 2022 Aug 05, 2022	SELL	$1.69 - $3.31 $84,736 - $165,963	-50,140 Reduced 57.71%	36,748 $79,000
Q1 2022 May 12, 2022	SELL	$2.65 - $3.49 $86,615 - $114,070	-32,685 Reduced 27.33%	86,888 $273,000
Q4 2021 Feb 10, 2022	SELL	$3.13 - $3.73 $250,400 - $298,400	-80,000 Reduced 40.09%	119,573 $384,000
Q3 2021 Nov 12, 2021	SELL	$3.31 - $4.04 $191,950 - $234,283	-57,991 Reduced 22.52%	199,573 $671,000
Q2 2021 Aug 12, 2021	BUY	$3.3 - $4.49 $19,140 - $26,042	5,800 Added 2.3%	257,564 $1.01 Million
Q1 2021 May 13, 2021	BUY	$2.42 - $4.47 $47,686 - $88,081	19,705 Added 8.49%	251,764 $1.01 Million
Q4 2020 Feb 16, 2021	BUY	$2.28 - $6.84 $187,119 - $561,358	82,070 Added 54.72%	232,059 $536,000
Q3 2020 Nov 12, 2020	SELL	$5.39 - $8.24 $215,481 - $329,418	-39,978 Reduced 21.04%	149,989 $861,000
Q2 2020 Aug 13, 2020	BUY	$2.67 - $7.91 $83,784 - $248,215	31,380 Added 19.79%	189,967 $1.4 Million
Q1 2020 May 13, 2020	BUY	$2.03 - $4.35 $321,931 - $689,853	158,587 New	158,587 $472,000

Others Institutions Holding OVID

# of Institutions

Shares Held

39.2M

Call Options Held

10.3K

Put Options Held

200

Rubric Capital Management LP New York, NY

5.32M
Shares

$6.27 Million
0.12% of portfolio
Madison Avenue Partners, LP New York, NY

4.08M
Shares

$4.82 Million
0.53% of portfolio
Black Rock Inc. New York, NY

3.99M
Shares

$4.71 Million
0.0% of portfolio
Bvf Inc San Francisco, CA

3.85M
Shares

$4.55 Million
0.09% of portfolio
Vanguard Group Inc Valley Forge, PA

3.09M
Shares

$3.65 Million
0.0% of portfolio

View Full List

About Ovid Therapeutics Inc.

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $83.1M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

More about OVID

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account